Everest Organics Ltd
Everest Organics (BSE)


Proj. ROE (%)
Proj. P/E (x)
Proj EV / EBITDA (x)
Proj. P/BV (x)
Proj. Revenue ( Cr.)

Stock View

Share on
The average score for Everest Organics Ltd stands at 2 against 2, three months back.

Everest Organics Limited is a India-based pharmaceutical company. The Company is engaged in the manufacturing and exporting of active pharmaceutical ingredients (APIs) and intermediates in India. It is involved in manufacturing of bulk drugs, such as Omeprazole, Ciprofloxacin, Dichloroflurobenzene, and Benzimadizole. The Company’s API’s products include PANTOPRAZOLE SODIUM SESQUIHYDRATE- USP/BP/EP/IP, ESOMEPRAZOLE MAGNESIUM TRIHYDRATE - USP/BP/IP/EP, OMEPRAZOLE MAGNESIUM - IP/EP/USP, OMEPRAZOLE SODIUM - IP / EP, ESOMEPRAZOLE SODIUM, PREGABALIN - IP, and 10. FENOFIBRATE -USP/BP/EP. Its intermediates includes 2-MERCAPTO-5-METHOXY BENZIMIDAZOLE (Omeprazole-Benzimidazole), AMMONIUM SULPHATE, TRISODIUM ORTHOPHOSPHATE (TSP), SODIUM NITRITE, DISODIUM ORTHO PHOSPHATE, and DI AMMONIUM PHOSPHATE. Its products under development includes SITAGLIPTIN, VILDAGLIPTIN, ILAPRAZOLE, NITRO LANSOPRAZOLE (NON INFRINGING), ESOMEPRAZOLE MAGNESIUM DIHYDRATE, LANSO CHLORO COMPOUND, and LANSO SULPHIDE.

Disclaimer : All estimates (1 year forward) are based on Consensus View provided by Refinitiv.

Technical Data
50 DMA()
100 DMA ()
200 DMA ()
52 Weeks Range
Street View :-
Open ZERO Brokerage Demat Account
Open Demat Account

  • 0

    Per Order for ETF & Mutual Funds Brokerage

  • 20

    Per Order for Delivery, Intraday, F&O, Currency & Commodity